For Partners.

Collaborating for Scientific Impact

At MVT in Silico, we believe transformative science happens through strong collaboration. We partner with academic institutions, biotech innovators, pharmaceutical sponsors, and technology platforms to integrate complementary expertise and accelerate discovery. Much like leading bio simulation and drug development companies that co-create shared R&D value with partners across the drug discovery range, our partnerships aim to bridge computational prediction with experimental validation and real world scientific needs.

What We Offer Our Partners

We provide access to advanced in silico modeling, curated datasets, and reproducible simulation workflows that enhance decision-making in early target identification, candidate optimization, and translational strategy. Our flexible collaboration models from research-as-a-service to tailored project engagements are built to complement partners' strengths while jointly addressing complex biological challenges. Inspired by collaborative frameworks that enable shared R&D risk and reward, we seek synergies that deepen scientific insight and accelerate therapeutic progress.

Current & Future Collaborations

Our existing collaborations include interdisciplinary scientific alliances and joint project work with domain experts across computational biology, pharmacology, and systems modeling (expand with specific organizations or labs, if applicable). Looking ahead, we are actively engaging with preclinical research centers, technology integrators, and industry partners to scale the reach and impact of our in silico platform. We invite organizations that share our vision of ethical, data-driven drug discovery to explore partnership opportunities with MVT in Silico.